Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from MicroPort Scientific ( (HK:0853) ) is now available.
MicroPort Scientific has deconsolidated its subsidiary MicroPort NeuroScientific Corporation after the appointment of an independent non-executive director shifted the balance of control on the Target Company’s board, leaving MicroPort with significant influence but no longer accounting control. As a result, MicroPort will treat the neuro-interventional device maker as an associate rather than a subsidiary, and expects to recognize a deemed gain on disposal in its consolidated financial statements, calculated with reference to the fair value of its remaining equity stake and the Target Company’s net assets, which were about RMB1.72 billion as of 30 June 2025; the gain remains subject to audit and may affect reported earnings and balance sheet structure.
The most recent analyst rating on (HK:0853) stock is a Hold with a HK$11.00 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.
More about MicroPort Scientific
MicroPort Scientific, incorporated in the Cayman Islands and listed on Hong Kong’s Main Board, is a leading global medical device group that innovates, manufactures and markets high-end devices across multiple segments, including cardiovascular and orthopedic products, endovascular and peripheral vascular devices, structural heart intervention and cardiac rhythm management solutions, as well as surgical robots and other related businesses.
Average Trading Volume: 15,748,206
Technical Sentiment Signal: Hold
Current Market Cap: HK$20.85B
For an in-depth examination of 0853 stock, go to TipRanks’ Overview page.